Snehal Patel compensation by year
Greenwich LifeSciences Summary Compensation Table · all 7 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Salary | $0 | $114,966 | $450,000 | $506,250 | $556,875 | $612,563 | $735,075 |
| Bonus | $0 | $392,516 | $475,000 | $503,125 | $528,438 | $306,281 | $367,538 |
| Stock awards | $122,750 | $491,589 | $491,589 | $1,201,050 | $1,664,716 | $5,322,841 | $4,898,642 |
| Option awards | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 | — | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | — | $0 | $0 |
| All other | $16,423 | $0 | $0 | $0 | — | $0 | $0 |
| Total | $139,173 | $999,071 | $1,416,589 | $2,210,425 | $2,750,028 | $6,241,685 | $6,001,255 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Greenwich LifeSciences, Inc. DEF 14A filed October 26, 2026, accession 0001493152-26-048537, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Greenwich LifeSciences, Inc. filed document, accession 0001493152-26-048537. Every figure is read from that document and cited to the page and table it appears in. Filed October 26, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 679,048 | — | $7.63 |
| Option | 995,723 | — | $12.16 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Greenwich LifeSciences, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
The full Greenwich LifeSciences compensation record
free company briefThis page is one person within Greenwich LifeSciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Greenwich LifeSciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Greenwich LifeSciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order GLSI
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.